NCT05099471
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05099471
Title Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia (VIWA-1)
Acronym VIWA-1
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Christian Buske
Indications
Therapies
Age Groups: adult | senior
Covered Countries GRC | DEU

Facility Status City State Zip Country Details
Onkologische Schwerpunktpraxis Bielefeld RECRUITING Bielefeld 33604 Germany Details
Klinikum Chemnitz gGmbH RECRUITING Chemnitz 09116 Germany Details
Klinikverbund Allgaeu gGmbH RECRUITING Kempten 87439 Germany Details
Universitaetsklinikum Schleswig-Holstein AöR NOT_YET_RECRUITING Kiel 24105 Germany Details
Gemeinschaftsklinikum Mittelrhein gGmbH RECRUITING Koblenz 56073 Germany Details
Dr. Vehling-Kaiser MVZ GmbH RECRUITING Landshut 84036 Germany Details
Kliniken Maria Hilf GmbH Moenchengladbach RECRUITING Mönchengladbach 41063 Germany Details
Haematologie und Onkologie Muenchen-Pasing MVZ GmbH RECRUITING München 81241 Germany Details
Universitaet Muenster RECRUITING Münster 48149 Germany Details
University Hospital Ulm RECRUITING Ulm 89081 Germany Details
Alexandra Hospital RECRUITING Athens 115 28 Greece Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field